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Abstract
Background: In order to manage the acute and long-term effects of living with a chronic disease such as diabetes,
both medical treatment and good psychosocial support are needed. In this study, we wish to examine whether a
psychological group intervention targeting people with poorly controlled type 1 diabetes can be helpful in augmenting
quality of life while also lowering participants’ HbA1c level. The group intervention will consist of a brief treatment
developed from a branch of cognitive behavioural therapy called acceptance and commitment therapy, which is part
of the so-called third wave of cognitive behavioural therapy. Common for these third-wave therapies, the focus is less
on the content and restructuring of thoughts and more on the function of behaviour. Here, we describe the protocol
and plans for study enrolment.
Methods/Design: This on-going study is designed as a randomised wait-list controlled trial. Eighty patients aged 26–55
years and with an HbA1c level >70 mmol/mol at the time of enrolment will be included.
Discussion: In this study, we will assess the effect of starting acceptance and commitment therapy group treatment for
patients with type 1 diabetes and its effect on glycaemic control and well-being.
Trial registration: Current controlled trials: ISRCTN17006837, registered 12th January 2015
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Background
The role of nursing, psychology and behaviour medicine
in the management of diabetes has gained increasing at-
tention in the past decade, but the field is still young
and rather narrow in scope [1–3]. Some of the progress
made in diabetes treatment has helped to ease the bur-
den of living with diabetes, while some of the advances
have also called for more intensive and demanding self-
care [4, 5]. In order to manage both the acute and long-
term effects of living with a chronic disease such as
diabetes, both medical treatment and good psychosocial
support are needed [6].
Among patients with diabetes, psychiatric co-morbidity
is associated with poorer glycaemic control [7, 8] and con-
tributes (along with genetic variation and other stress
factors) to why so few patients with diabetes reach gly-
caemic control goals. People with diabetes are two to four
times more likely to be diagnosed with depression than
those without the disease [4, 9–11]. The repetitive prac-
tical and emotional burdens that often accompany the
self-management of diabetes play an important role in the
increased risk of depression [12].
Acceptance and commitment therapy
Acceptance and commitment therapy (ACT) is part of
the so-called third wave of cognitive behavioural therapy
(CBT). Common to these third-wave therapies, focus is
less on the content and restructuring of thoughts and
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more on the function of behaviour. In practise, these
therapies focus on teaching patients skills of coping and
empowerment, such as strategies of acceptance and
mindfulness [13].
The theoretical background of ACT is based on func-
tional contextualistic philosophy of science and modern
learning theory, mainly relational frame theory and con-
textual behavioural science. Both theories strive to under-
stand human behaviour and language from its context and
use this knowledge to predict and influence behaviour.
ACT can be seen as a unified model of behavioural change,
rather than a specific set of methods or techniques [13].
Similar to CBT, ACT acknowledges the relevance of
language and cognition in psychopathology and psycho-
therapy, but ACT does not consider thoughts and beliefs
to directly cause other behaviours. Therefore, it is seen
as unnecessary to target the content of thoughts in order
to promote behavioural change. Instead, thoughts are
valued the most for their usefulness in achieving a more
valued life [13].
From an ACT perspective, psychological and physical
pain is unavoidable and a natural part of the human con-
dition—sickness, death, separation and other large and
small disappointments are bound to happen to us if we
lead a life that matters to us. While pain might be part of
the human condition, suffering does not have to be.
Suffering is considered to be caused by our ability
through language to categorise, predict, evaluate, remin-
isce about the past and worry about things yet to come.
Since this stance of accepting pain can be provocative for
some patients, it is important in treatment to emphasise
that accepting pain is not a passive state but a proactive
stance that focuses on behaving in ways that lead to better
health and quality of life (QoL).
Accepting the inevitability of pain and struggle, includ-
ing physical illness and distress, is the first step towards
psychological flexibility. The overarching goal in a treat-
ment using ACT is thus to increase patients’ psychological
flexibility concerning thoughts, feelings and behaviour.
Psychological flexibility is the ability to accept one’s own
difficult feelings and thoughts while at the same time
striving to live a meaningful life according to one’s per-
sonal values [13]. Thus, psychological flexibility involves
adjusting behaviour according to the current situation in a
helpful manner and not by the ebb and flow of thoughts
and emotions. The opposite, psychological inflexibility,
can include sticking to a behaviour and mind-set even
though it continues to create suffering. Psychological in-
flexibility is often manifested as emotional avoidance, i.e.,
the attempt to avoid or ignore unpleasant thoughts, emo-
tions and situations. In ACT, emotional avoidance is seen
as the main reason why humans suffer from psychological
illness. This emotional avoidance can take many forms,
such as avoidance of close relationships, distractions such
as excessive game playing, binge eating and the use of
drugs or alcohol. These strategies are negatively reinforced
as they offer somewhat temporary relief from unpleasant
experiences.
Experiential avoidance is not negative per se, but
often becomes a problem when it leads to psychological
inflexibility and stands in the way of leading a rich and
valued life [14].
The ACT model of psychological flexibility is based upon
six core processes: acceptance, verbal defusion, mindful-
ness, self-as-context, values and committed action. In ther-
apy, these processes are targeted through exercises and
values clarification. As ACT is a behavioural therapy, the
focus lies in experience-based learning, both in-session and
as committed actions to try in-between sessions. In sum-
mary, experiential avoidance and psychological inflexibility
may be important factors in many diabetes patients’ strug-
gle with self-care. Avoidance can make a person ignore
recommendations or behave in ways that are not helpful,
such as not monitoring blood sugar levels. Inflexibility
may manifest as resistance to change and difficulties in
adapting to new circumstances. Helping patients to im-
prove in these factors may thus help improve self-care
and health.
Empirical evidence
The current empirical evidence for ACT is rapidly emer-
ging, but is still not as sound as the evidence for CBT.
ACT is approved as evidence-based practice for the treat-
ment of depression and chronic pain by the American
Psychological Association. Other areas for implementation
are also being considered [15] ACT has been tested in nu-
merous behavioural medicine areas such as pain [16],
chronic physical diseases [17] and obesity [18, 19], with
data showing preliminary good results.
The Swedish institute for assessing health care inter-
ventions, SBU, issued a report on diabetes care in 2009
in which they stated that more studies were needed in
order to assess the effectiveness of CBT and other inter-
ventions for individuals with type 1 diabetes [20]. In a
Swedish randomised controlled trial, Amsberg et al. [21]
tested the effectiveness of CBT (primarily administered
in a group setting) in patients with diabetes. The study
specifically aimed at maintaining behaviour change, as
previous studies have shown that improvements made dir-
ectly post-treatment are rarely maintained during follow-
up. In the study, the 40 participants in the intervention
group significantly improved regarding glycaemic control
as measured by HbA1c level, diabetes-related distress,
well-being, perceived stress, anxiety and depression, as
well as frequency in self-monitoring of blood glucose in
comparison to the control group.
To date, there has only been one study testing the ef-
fectiveness of ACT in a diabetes population of patients
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with type 2 diabetes. The study randomly allocated 81
patients to either a control group (in which participants
received education about how to manage their diabetes)
or to an ACT intervention. Participants in the ACT inter-
vention group received the same education, as well as a 1-
day ACT workshop, where the participants were taught
how to apply mindfulness and acceptance skills to difficult
thoughts and emotions. After 3 months, the participants
in the ACT group were more likely to use these coping
strategies and reported better diabetes self-care as well as
having an HbA1c value in the target range [22].
Study aim
For this study, we wish to examine whether a psycho-
logical group intervention targeting people with poorly
controlled type 1 diabetes can be helpful in augmenting
QoL while also lowering participants’ HbA1c level. The
group intervention will consist of seven sessions of ACT
and three follow-up sessions on glycaemic control and
well-being.
Methods/Design
Study design and setting
The design of this study is a randomised wait-list con-
trolled trial. The study will be conducted at Akademiska
sjukhuset, Uppsala University Hospital, Uppsala.
Participants and recruitment
Eighty patients aged 26–55 years with an HbA1c level
>70 mmol/mol at the time of enrolment will be included.
Exclusion criteria to the study will be ongoing severe de-
pression, eating disorders or other severe mental illnesses,
alcohol or substance abuse, or severe diabetes complica-
tions. Oral and written information about the present
study will be given to patients who fulfil the inclusion cri-
teria. Written informed consent or assent for participation
in the study will be obtained from the participants.
Randomisation
Participants who fulfil the inclusion criteria and are will-
ing to participate in the study and have completed the
pre-test will be randomly allocated to either the inter-
vention or wait-list control group. A flow chart of the
study is shown in Additional file 1.
Intervention
The treatment is scheduled to run over a period of
6 months. Participants in the treatment condition will
learn mindfulness and acceptance strategies to cope with
diabetes-related distress. The treatment will focus on living
according to one’s values and on behavioural activation. As
the treatment is targeted towards a population with poorly
controlled diabetes, the intervention will also include
1 week of measurements with a hidden continuous glucose
monitoring system so that patients can see how their be-
haviour influences their blood glucose levels. All sessions
will be led by a psychologist with specialisation in CBT
and training in ACT, and a nurse specialised in diabetes.
Each session will have an ACT-specific theme about how
to promote psychological flexibility. The topics will include
the acceptance of thoughts and feelings, and mindfulness.
Exercises in mindfulness will be based in concrete practice,
both during the course sessions and as homework. Accept-
ance will be practiced through experiential exercises, writ-
ing exercises and discussion. Each patient will commit to
what is important for him or her to focus on in the next
follow- up visit. The treatment session protocol is included
in Additional file 2.
Measures and data collection
Before starting ACT we will collect the following data
from the participants: HbA1c level, height, weight, insu-
lin requirements, mean frequency of self-monitoring of
blood glucose, Hospital Anxiety and Depression scale
(HADS), ‘Check your health’ scale, and the Acceptance
and Action Questionnaire 2 (AAQ2). These data will
also be collected 6 and 12 months after starting ACT.
HADS
The original HADS, which measures anxiety and depres-
sion, was developed by Zigmond and Snaith [23]. The
HADS consists of 14 items, of which seven relate to anx-
iety and seven to depression. Responses are rated on a
four-point Likert scale score (0–3), where 0 represents the
lowest level of anxiety and depression and 3 the highest
level. The Swedish version of HADS has been used in this
study, which has been translated by Lisspers et al. [24].
Check your health
‘Check your health’ measures perceived physical and emo-
tional health, social relationships and general QoL on a
vertical thermometer scales, ranging from 0 to 100, with 0
indicating low perceived health and QoL. Using the same
scales, a person reports what their perceived physical and
emotional health, social relationships and QoL would be if
they did not have diabetes. The measured difference be-
tween, for example, physical health with and without dia-
betes is defined as the physical burden of diabetes. When
the difference results in a positive value, meaning that, for
example, imagined physical health without diabetes is re-
ported to be lower than that with diabetes, the burden is
interpreted as zero. In this study, the marginal values for
no burden, low burden, high burden or very high burden
will be arbitrary. ‘Check your health’ has been tested on
adolescents and adults with diabetes and has shown good
reliability and validity [25, 26].
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AAQ2
AAQ2 is a self-assessment questionnaire designed to meas-
ure psychological acceptance/flexibility and emotional
avoidance, and how these two factors affect the individual’s
freedom of action. The instrument includes 10 items in the
form of statements that the respondent takes a position on
in a seven-point Likert scale (1 = never true, 7 = always
true), although seven of the 10 items are reversed (2, 3, 4, 5,
7, 8 and 9). Scores are calculated by summing the scores
from the 10 items. Higher total values indicate a higher de-
gree of flexibility [27].
Statistical analysis and power calculation
To detect a difference of 6 mmol/mol in HbA1c (SD ± 11)
at least 35 participants are needed in each group (power
80 % and alfa 0.05). In view of the drop-off, 80 patients
will be included. The differences between the groups will
be analysed with unpaired t-tests with 95 % confidence
intervals and p < 0.05 considered as significant. Repeated-
measures analysis of variance will be used for comparisons
in the groups in pre- and post-measuring with the same
confidence interval and level of significance. When testing
differences between groups regarding AAQ2 and ‘Check
your health’, the same statistical analysis will be used.
Ethical considerations
The ethical review board in Uppsala, Sweden, has approved
the study (2014/301).
Discussion
The aim of this study is to test the effects of an ACT
group treatment and its effect on glycaemic control and
well-being. ACT is a modern psychological intervention.
Previous studies have reported good preliminary
results for ACT in numerous behavioural medicine
areas [13, 28–30].
We have chosen to include patients with higher HbA1c
values (above 70 mmol/mol) because we want to see if the
participants using the tools they receive from ACT treat-
ment can lower their HbA1c level and also experience im-
proved well-being. To detect changes in perceived physical
health, general QoL and the burden of diabetes, we will use
the HADS, ‘Check your health’ scale and AAQ2. The inter-
vention will take 7 weeks and perceived QoL will be evalu-
ated at baseline, 6 and 12 months to allow comparisons
and to determine any changes.
Sweden has a national register that includes 90 % of all
patients. Data from this register show that HbA1c level is
increasing every year for patients with type 1 diabetes
[31]. This finding highlights the need to take strong mea-
sures to help patients achieve optimal glycemic control
while maintaining a good QoL, especially as good gly-
caemic control prevents or postpones complications.
The prevalence of depression is overrepresented in pa-
tients with diabetes, which indicates the need for psycho-
logical support. Psychiatric co-morbidity is associated with
poorer glycaemic control among patients with diabetes
[7]. Diabetes is a disease in which self-care is ongoing;
therefore, the patient is the most important partner in the
team, in collaboration with nurses and clinicians, includ-
ing a psychologist. A psychologist and diabetes specialist
nurse will lead this ACT study.
In a study with similar ambitions to this study, patients
with type 2 diabetes had a 1- day training workshop with
ACT [22]. After 3 months, these patients were more likely
to use these coping strategies, reported better diabetes
self-care and had HbA1c values within the target range
No studies have been conducted in participants with type
1 diabetes. Thus, there is a lack of evidence in the field,
and the intent of this study is to address this gap.
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